ArticleCase reports in ophthalmological medicine2021
Bilateral Ampiginous Choroiditis following Presumed SARS-CoV-2 Infection.
Article in Case reports in ophthalmological medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 17 citations in OpenAlex.
- Long-term follow-up of a bilateral acute posterior multifocal placoid pigment epitheliopathy following COVID-19 infection: a case report.Journal of ophthalmic inflammation and infection · 2024Article
- Acute posterior multifocal placoid pigment epitheliopathy following COVID-19 infection.American journal of ophthalmology case reports · 2023Article
- Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies.Frontiers in pediatrics · 2023Review
- Tubercular serpiginous choroiditis.Journal of ophthalmic inflammation and infection · 2022Review
- Update on overview of ocular manifestations of COVID-19.Frontiers in medicine · 2022Review
- An acute posterior multifocal placoid pigment epitheliopathy with presumed systemic lupus erythematosus etiology.Oman journal of ophthalmologyArticle
- Bilateral ampiginous choroiditis after COVID-19: a report of two cases.Romanian journal of ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report a case of bilateral ampiginous choroiditis following presumed SARS-CoV-2 infection.
conclusionsAmpiginous choroiditis is an inflammatory chorioretinopathy with an unknown pathogenic mechanism that often necessitates early immunomodulatory therapy. This report suggests that SARS-CoV-2 infection may trigger chorioretinal inflammation in susceptible hosts.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.